ArticleClinical & translational immunology2022

Targeting SARS-CoV-2 infection through CAR-T-like bispecific T cell engagers incorporating ACE2.

Mikail Dogan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.